See You In September: Cephalon Anticipates Generic Actiq Ahead Of Fentora Follow-On
This article was originally published in The Pink Sheet Daily
Executive Summary
Barr reports plans to begin selling a generic version of the pain drug in the second half of September.
You may also be interested in...
Cephalon’s Fentora Approved For Breakthrough Cancer Pain
Barr is free to launch generic of Actiq, Fentora’s predecessor.
Cephalon’s Fentora Approved For Breakthrough Cancer Pain
Barr is free to launch generic of Actiq, Fentora’s predecessor.
Spar-Gone: Cephalon Drops Sparlon Following "Non-Approvable" Letter
FDA also extends user fee date for Nuvigil to December to analyze safety data.